Asthma and Allergic Diseases Cooperative Research Centers

The National Institute of Allergy and Infectious Diseases is preparing to renew support for the Asthma and Allergic Diseases Cooperative Research Centers program, a pivotal initiative designed to drive multidisciplinary, multi-center translational research into asthma and a range of allergic conditions including upper airway diseases, food and drug allergies, and atopic dermatitis. This program serves as the flagship mechanism for NIAID to deepen understanding of disease mechanisms, progression, and treatment responses through clinical and basic research, often leveraging human samples and conducting small-scale clinical or observational studies focused on immune pathways. Emphasis is placed on integrating diverse scientific approaches to bridge discoveries from bench to bedside and improve therapeutic outcomes. The solicitation, forecasted for release on June 24, 2026, is authorized under Sections 301 and 405 of the Public Health Service Act and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. It is open to research teams capable of building collaborative, cross-institutional efforts, as the AADCRC is the only NIAID program specifically structured to foster such integrated research in allergic diseases. The Division of Allergy, Immunology, and Transplantation serves as the primary point of contact, with inquiries directed to aadcrc_u19@mail.nih.gov. The forecast indicates an upcoming opportunity for organizations to compete for funding to establish or continue center-based research programs aligned with NIAID’s mission to advance the prevention, diagnosis, and treatment of allergic diseases.